showed a trendp = 0.06
Furthermore, at one year baseline FFR CT below 0.80 showed a trend ( p = 0.06) towards higher occurrence of adverse cardiovascular events [ 65 ].
Furthermore, at one year baseline FFR CT below 0.80 showed a trend ( p = 0.06) towards higher occurrence of adverse cardiovascular events [ 65 ].
Mood showed a trend toward slight variation during the evening (main effect of time; p = 0.06) and was significantly better in winter than in summer (main effect of season; F 1,517 = 37.68; p < 0.0001; Figure 5 E) without differences between cataracts and pseudophakes ( p = 0.27; or an interaction between these factors; p = 0.45).
A high tumor OPN protein level was significantly related to tumor grade (p = 0.003) and an increased rate of relapse (p = 0.02), and also showed a trend association with high tumor stage (p = 0.06) (Table 3 ).
Tennis players showed a trend to greater volume in the non-dominant compared to the dominant gluteal muscles (8%, P = 0.06), whilst similar GL muscles volumes were observed in both sides in SP and CG (P = 0.87 and P = 0.94, respectively) ( Fig. 1B ).
The A allele of rs1447295 was significantly associated with the risk of sporadic prostate cancer ( p = 0.04; age-adjusted OR, 1.34), while the G allele of rs6983267 showed a trend towards being a high-risk allele ( p = 0.06; age-adjusted OR, 1.27).
Here, the pol3-t strain showed a trend of a lower induction rate than that of wild type: 19.8 ± 4.3 versus 35.6 ± 13.2 (×10 −3 per Gy) ( P = .06). 4.
Moreover, the G-based group showed a trend for a worse PS compared with the F-based group (P = 0.06).
In men, ratings of difficulties in intimacy was positively correlated with cybersex ratings r = 0.47, p < 0.01 and with pornography ratings r = 0.48, p < 0.01 whereas in women, ratings of difficulties in intimacy was not correlated with cybersex ratings r = 0.11, p = N.S and with pornography ratings it only showed a trend of a positive correlation r = 0.22, p = 0.06.
Transfusion requirements for packed red cells were not different between the groups (ADR: 250 ± 322 ml; MIL: 204 ± 245 ml; CON: 87 ± 167 ml), whereas requirements for fresh frozen plasma showed a trend ( p = 0.06) for a higher use in the ADR and MIL groups (ADR: 107 ± 196 ml; MIL: 68 ± 161 ml; CON: 0 ± 0 ml).
The difference in the fraction of breast cancer patients with an elevated bFGF serum level (58%) and colorectal cancer patients with an elevated bFGF serum level (33%) showed a trend towards significance (chi-squared test P = 0.06).
No significant differences were observed among groups in glucose area under the curve (AUC) values, although the H group showed a trend versus control (p = 0.06).
Mean changes in LDL-C showed a trend to improvement and leveled off after 20 days since treatment intensification (p = 0.06).
Following single marker analysis of the test dataset, one SNP mapping close to loc154449 showed a trend towards allelic association (rs11752069, p = 0.06) with RA and significant genotypic association with RA (p = 0.05).
The higher dose of letrozole showed a trend ( P = 0.06) toward superior ORR (19.5%) compared with aminoglutethimide (12.4%).
The overall pooled estimate across both time points showed a trend toward improvement that did not reach statistical significance (mean difference: 21.27, 95% CI: −0.96 to 43.50, p = 0.06), with substantial heterogeneity observed ( I 2 = 80%, p = 0.03).
As shown in Figure 3 , General Emotional Distress was significantly and positively correlated with Stress Level (r = 0.17, p = 0.006), while Stress Response showed a trend toward statistical significance (r = 0.12, p = 0.06); Stress Recovery was not significantly associated.
In the test cohort, plasma EGF and MIP-1β/CCL4 statistically differed in both classification groups (p<0.0001 and p = 0.0002, respectively); in the validation cohort, both analytes showed a trend (p = 0.06) to be at lower concentrations in the plasma of progressive patients (SP-MS and PP-MS) than in RR-MS patients ( Table 3 ).
Individuals with the risk allele genotype of rs33912345 showed a trend of thinner RNFL in the temporal sector, again not statistically significant (A/A 72.8 ± 10.0 μm, A/C 72.0 ± 9.0 μm, C/C 71.2 ± 9.8 μm, p = 0.06).
As shown in Table 6 , mTOR showed a trend of association with lymph node metastasis (OR = 1.72, 95%CI 0.98–3.01, P = 0.06) and late TNM stage (OR = 3.13, 95%CI 0.72–13.61, P = 0.13).
MOGAD eyes showed a trend to a similar association (Beta = 653.78 ± 329.25; p = 0.06, Fig. 4 b) while MS-ON eyes also showed a significant albeit smaller positive association (Beta = 315.02 ± 130.76; p = 0.02, Fig. 4 c).
Surprisingly, we found that relative circulating levels of GnRH showed a trend towards reduction in Mecp2 CD1 ‐null as compared to WT males ( t 12 = 2.08; p = .06; Figure 4A ).
At 24 months, PFDI-20 showed a trend toward lower scores in the LLSHE group (38.0 [17.0–53.0] vs. 48.0 [34.2–59.0]; P = 0.060), as did PFIQ-7 (23.0 [4.0–40.0] vs. 30.0 [16.0–43.2]; P = 0.255), though neither reached statistical significance.
These results extend our 2-year study showing that discontinuation of ASMs before hospital discharge is safe 5 and provides additional support for the ILAE recommendation that “following cessation of acute provoked seizures without evidence for neonatal-onset epilepsy, ASMs should be discontinued before discharge home, regardless of magnetic resonance imaging or electroencephalographic findings.” 14 Adjusted FSIQ at age 5 to 6 years showed a trend toward significantly higher IQ in the children whose ASMs were discontinued prior to hospital discharge (adjusted difference +10 points, p = .06).
The level of GHRL, a key appetite-stimulating hormone, showed a trend of increase by 3.90% ( p = 0.06).
Overall, receipt of any adjuvant therapy versus no adjuvant therapy ( n = 298) showed a trend toward improved outcomes for RFS (HR 0.79, 95% CI 0.62-1.0, P = 0.06) and DRFS (HR 0.78, 95% CI 0.61-1.004, P = 0.06), and statistically significant improvement in OS (HR 0.71, 95% CI 0.54-0.93, P = 0.01).